Table 3.
Clinicopathological characteristics of RRMS patients and control samples (N = 71).
| Patient demographics and laboratory information | RRMS (N = 51) | Control (N = 20) | P value |
|---|---|---|---|
| Average age | 36.12±10.28 | 37.90±13.19 | 0.547 |
| Sex (female) | 39 (76.47%) | 15 (75.00%) | 0.238 |
| Oligoclonal band positive | 20 (39.2%) | 0 | 0.001** |
| CSF IgG (mg/L) | 32.7 (21.9-54.5) | 20.2 (14.85-28.3) | 0.002** |
| CSF IgA (mg/L) | 2.85 (1.76-4.14) | 2.23 (1.4-2.67) | 0.056 |
| CSF IgM (mg/L) | 0.45 (0.29-0.89) | 0.32 (0.23-0.41) | 0.049* |
| CSF Alb (mg/L) | 172 (138-204) | 162.5 (124.5-199) | 0.494 |
| CSF total cell count (106/L) | 5 (0-10) | 1 (0-6.5) | 0.122 |
| CSF WBC count (106/L) | 1 (0-4) | 0 (0-1.5) | 0.26 |
| CSF protein (mg/L) | 328.53 (282.84-403.98) | 287.52 (238.04-351.98) | 0.089 |
*p < 0.05, **p < 0.01.